Although there are certain differences in the roles of complements C3 and C4 and CRP in the differential diagnosis of SLE and RA (21,22), our results revealed that in SLE and RA patients of Northern China, C3, C4 and CRP may be used for the differential diagnosis, symptom prediction and disease progress evaluation. This evidence concerns the gene CRP and rheumatoid arthritis.